APO Research
Talk to an analyst

APO RESEARCH · REPORT

Mesenchymal Stem Cells

Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.

Selected research

Market Outlook & Growth Opportunities

Global Mesenchymal Stem Cells Market Outlook and Growth Opportunities 2026

2 January 2026195 pages

Choose your research edition.

Industry ResearchMesenchymal Stem Cells Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesenchymal Stem Cells Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Mesenchymal Stem Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesenchymal Stem Cells Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesenchymal Stem Cells Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Mesenchymal Stem Cells (MSC), also termed Mesenchymal Stromal Cells, are multipotent cells that can differentiate into a variety of cell types and have the capacity for self-renewal. MSC have been shown to differentiate in vitro or in vivo into adipocytes, chondrocytes, osteoblasts, myocytes, neurons, hepatocytes, and pancreatic islet cells. Optimized PromoCell media are available to support both the growth of MSC and their differentiation into several different lineages. Recent experiments suggest that differentiation capabilities into diverse cell types vary between MSC of different origin.

The top 3 manufacturters of Mesenchymal Stem Cells include ​Lonza, Thermo Fisher and Bio-Techne, with about 56% market shares.

North America region is the largest consumption of Mesenchymal Stem Cells, with a sales revenue market share nearly 41%. Europe is the second largest consumer of Mesenchymal Stem Cells, enjoying sales revenue market share about 31%.

Read the full market overview

This report provides an overview of the global Mesenchymal Stem Cells market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Mesenchymal Stem Cells and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Mesenchymal Stem Cells revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Mesenchymal Stem Cells market.

Mesenchymal Stem Cells Segment by Company

Lonza

Thermo Fisher

Bio-Techne

ATCC

MilliporeSigma

PromoCell GmbH

Genlantis

Celprogen

Cell Applications

Cyagen Biosciences

Axol Bioscience

Mesenchymal Stem Cells Segment by Type

Human MSC

Mouse MSC

Rat MSC

Others

Mesenchymal Stem Cells Segment by Application

Research Institute

Hospital

Others

Mesenchymal Stem Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Mesenchymal Stem Cells status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Mesenchymal Stem Cells key companies, revenue, market share, and recent developments.

3. To split the Mesenchymal Stem Cells breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Mesenchymal Stem Cells market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Mesenchymal Stem Cells significant trends, drivers, influence factors in global and regions.

6. To analyze Mesenchymal Stem Cells competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesenchymal Stem Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesenchymal Stem Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesenchymal Stem Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Mesenchymal Stem Cells industry.

Chapter 3: Detailed analysis of Mesenchymal Stem Cells company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Mesenchymal Stem Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Mesenchymal Stem Cells in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Mesenchymal Stem Cells Industry Trends Table 2. Mesenchymal Stem Cells Industry Drivers Table 3. Mesenchymal Stem Cells Industry Opportunities and Challenges Table 4. Mesenchymal Stem Cells Industry Restraints Table 5. Global Mesenchymal Stem Cells Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Mesenchymal Stem Cells Revenue Share by Company (2021-2026) Table 7. Global Mesenchymal Stem Cells Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Mesenchymal Stem Cells Key Company Manufacturing Base & Headquarters Table 9. Global Mesenchymal Stem Cells Company, Product Type & Application Table 10. Global Mesenchymal Stem Cells Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Mesenchymal Stem Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Human MSC Table 15. Significant Companies of Mouse MSC Table 16. Significant Companies of Rat MSC Table 17. Significant Companies of Others Table 18. Global Mesenchymal Stem Cells Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Mesenchymal Stem Cells Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Mesenchymal Stem Cells Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Mesenchymal Stem Cells Sales Value Share by Type (2021-2026) Table 22. Global Mesenchymal Stem Cells Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Research Institute Table 24. Significant Companies of Hospital Table 25. Significant Companies of Others Table 26. Global Mesenchymal Stem Cells Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Mesenchymal Stem Cells Sales Value by Application (2021-2026) & (US$ Million) Table 28. Global Mesenchymal Stem Cells Sales Value by Application (2027-2032) & (US$ Million) Table 29. Global Mesenchymal Stem Cells Sales Value Share by Application (2021-2026) Table 30. Global Mesenchymal Stem Cells Sales Value Share by Application (2027-2032) Table 31. Global Mesenchymal Stem Cells Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Mesenchymal Stem Cells Sales Value by Region (2021-2026) & (US$ Million) Table 33. Global Mesenchymal Stem Cells Sales Value Share by Region (2021-2026) Table 34. Global Mesenchymal Stem Cells Sales Value by Region (2027-2032) & (US$ Million) Table 35. Global Mesenchymal Stem Cells Sales Value Share by Region (2027-2032) Table 36. Global Mesenchymal Stem Cells Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Mesenchymal Stem Cells Sales Value by Country (2021-2026) & (US$ Million) Table 38. Global Mesenchymal Stem Cells Sales Value Market Share by Country (2021-2026) Table 39. Global Mesenchymal Stem Cells Sales Value by Country (2027-2032) & (US$ Million) Table 40. Global Mesenchymal Stem Cells Sales Value Market Share by Country (2027-2032) Table 41. Lonza Company Information Table 42. Lonza Business Overview Table 43. Lonza Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 44. Lonza Mesenchymal Stem Cells Product Portfolio Table 45. Lonza Recent Development Table 46. Thermo Fisher Company Information Table 47. Thermo Fisher Business Overview Table 48. Thermo Fisher Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 49. Thermo Fisher Mesenchymal Stem Cells Product Portfolio Table 50. Thermo Fisher Recent Development Table 51. Bio-Techne Company Information Table 52. Bio-Techne Business Overview Table 53. Bio-Techne Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 54. Bio-Techne Mesenchymal Stem Cells Product Portfolio Table 55. Bio-Techne Recent Development Table 56. ATCC Company Information Table 57. ATCC Business Overview Table 58. ATCC Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 59. ATCC Mesenchymal Stem Cells Product Portfolio Table 60. ATCC Recent Development Table 61. MilliporeSigma Company Information Table 62. MilliporeSigma Business Overview Table 63. MilliporeSigma Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 64. MilliporeSigma Mesenchymal Stem Cells Product Portfolio Table 65. MilliporeSigma Recent Development Table 66. PromoCell GmbH Company Information Table 67. PromoCell GmbH Business Overview Table 68. PromoCell GmbH Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. PromoCell GmbH Mesenchymal Stem Cells Product Portfolio Table 70. PromoCell GmbH Recent Development Table 71. Genlantis Company Information Table 72. Genlantis Business Overview Table 73. Genlantis Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Genlantis Mesenchymal Stem Cells Product Portfolio Table 75. Genlantis Recent Development Table 76. Celprogen Company Information Table 77. Celprogen Business Overview Table 78. Celprogen Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Celprogen Mesenchymal Stem Cells Product Portfolio Table 80. Celprogen Recent Development Table 81. Cell Applications Company Information Table 82. Cell Applications Business Overview Table 83. Cell Applications Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Cell Applications Mesenchymal Stem Cells Product Portfolio Table 85. Cell Applications Recent Development Table 86. Cyagen Biosciences Company Information Table 87. Cyagen Biosciences Business Overview Table 88. Cyagen Biosciences Mesenchymal Stem Cells Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio Table 90. Cyagen Biosciences Recent Development Table 91. Axol Bioscience Company Information Table 92. Axol Bioscience Business Overview Table 93. Axol Bioscience Mesenchymal Stem Cells Sales (Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 94. Axol Bioscience Mesenchymal Stem Cells Product Portfolio Table 95. Axol Bioscience Recent Development Table 96. Research Programs/Design for This Report Table 97. Authors List of This Report Table 98. Secondary Sources Table 99. Primary Sources List of Figures Figure 1. Mesenchymal Stem Cells Product Image Figure 2. Global Mesenchymal Stem Cells Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesenchymal Stem Cells Market Size (2021-2032) & (US$ Million) Figure 4. Global Mesenchymal Stem Cells Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Human MSC Image Figure 8. Mouse MSC Image Figure 9. Rat MSC Image Figure 10. Others Image Figure 11. Global Mesenchymal Stem Cells Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Mesenchymal Stem Cells Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Mesenchymal Stem Cells Sales Value Share by Type (2021-2032) Figure 14. Research Institute Image Figure 15. Hospital Image Figure 16. Others Image Figure 17. Global Mesenchymal Stem Cells Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Mesenchymal Stem Cells Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Mesenchymal Stem Cells Sales Value Share by Application (2021-2032) Figure 20. Global Mesenchymal Stem Cells Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 21. Global Mesenchymal Stem Cells Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 22. North America Mesenchymal Stem Cells Sales Value (2021-2032) & (US$ Million) Figure 23. North America Mesenchymal Stem Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Europe Mesenchymal Stem Cells Sales Value (2021-2032) & (US$ Million) Figure 25. Europe Mesenchymal Stem Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Asia-Pacific Mesenchymal Stem Cells Sales Value (2021-2032) & (US$ Million) Figure 27. Asia-Pacific Mesenchymal Stem Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 28. South America Mesenchymal Stem Cells Sales Value (2021-2032) & (US$ Million) Figure 29. South America Mesenchymal Stem Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Middle East & Africa Mesenchymal Stem Cells Sales Value (2021-2032) & (US$ Million) Figure 31. Middle East & Africa Mesenchymal Stem Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 32. USA Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. USA Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. USA Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Canada Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Canada Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Canada Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Mexico Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Mexico Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Mexico Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Germany Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Germany Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Germany Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. France Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. France Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. France Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. U.K. Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. U.K. Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. U.K. Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Italy Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Italy Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Italy Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Spain Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Spain Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Spain Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Russia Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Russia Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Russia Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Netherlands Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Netherlands Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Netherlands Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Nordic Countries Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Nordic Countries Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Nordic Countries Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. China Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. China Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. China Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Japan Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Japan Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Japan Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. South Korea Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. South Korea Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. South Korea Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. India Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. India Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. India Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Australia Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Australia Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Australia Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Southeast Asia Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Southeast Asia Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Southeast Asia Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Brazil Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Brazil Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Brazil Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Argentina Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Argentina Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Argentina Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Chile Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Chile Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Chile Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Colombia Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Colombia Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Colombia Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Peru Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Peru Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Peru Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Saudi Arabia Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Israel Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Israel Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Israel Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. UAE Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. UAE Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. UAE Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Turkey Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Turkey Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Turkey Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Iran Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Iran Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Iran Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Egypt Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Egypt Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Egypt Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Years Considered Figure 117. Research Process Figure 118. Key Executives Interviewed

Scope & coverage.

Types
  • Human MSC
  • Mouse MSC
  • Rat MSC
  • Others
Applications
  • Research Institute
  • Hospital
  • Others
Companies covered
  • Lonza
  • Thermo Fisher
  • Bio-Techne
  • ATCC
  • MilliporeSigma
  • PromoCell GmbH
  • Genlantis
  • Celprogen
  • Cell Applications
  • Cyagen Biosciences
  • Axol Bioscience

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Mesenchymal Stem Cells Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Mesenchymal Stem Cells Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Mesenchymal Stem Cells Market Dynamics
  1. 2.1 Mesenchymal Stem Cells Industry Trends
  2. 2.2 Mesenchymal Stem Cells Industry Drivers
  3. 2.3 Mesenchymal Stem Cells Industry Opportunities and Challenges
  4. 2.4 Mesenchymal Stem Cells Industry Restraints
3 Mesenchymal Stem Cells Market by Company
  1. 3.1 Global Mesenchymal Stem Cells Company Revenue Ranking in 2025
  2. 3.2 Global Mesenchymal Stem Cells Revenue by Company (2021-2026)
  3. 3.3 Global Mesenchymal Stem Cells Company Ranking (2024-2026)
  4. 3.4 Global Mesenchymal Stem Cells Company Manufacturing Base and Headquarters
  5. 3.5 Global Mesenchymal Stem Cells Company Product Type and Application
  6. 3.6 Global Mesenchymal Stem Cells Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Mesenchymal Stem Cells Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Mesenchymal Stem Cells Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Mesenchymal Stem Cells Market by Type
  1. 4.1 Mesenchymal Stem Cells Type Introduction
  2. 4.1.1 Human MSC
  3. 4.1.2 Mouse MSC
  4. 4.1.3 Rat MSC
  5. 4.1.4 Others
  6. 4.2 Global Mesenchymal Stem Cells Sales Value by Type
  7. 4.2.1 Global Mesenchymal Stem Cells Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Mesenchymal Stem Cells Sales Value by Type (2021-2032)
  9. 4.2.3 Global Mesenchymal Stem Cells Sales Value Share by Type (2021-2032)
5 Mesenchymal Stem Cells Market by Application
  1. 5.1 Mesenchymal Stem Cells Application Introduction
  2. 5.1.1 Research Institute
  3. 5.1.2 Hospital
  4. 5.1.3 Others
  5. 5.2 Global Mesenchymal Stem Cells Sales Value by Application
  6. 5.2.1 Global Mesenchymal Stem Cells Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Mesenchymal Stem Cells Sales Value by Application (2021-2032)
  8. 5.2.3 Global Mesenchymal Stem Cells Sales Value Share by Application (2021-2032)
6 Mesenchymal Stem Cells Regional Value Analysis
  1. 6.1 Global Mesenchymal Stem Cells Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Mesenchymal Stem Cells Sales Value by Region (2021-2032)
  3. 6.2.1 Global Mesenchymal Stem Cells Sales Value by Region: 2021-2026
  4. 6.2.2 Global Mesenchymal Stem Cells Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Mesenchymal Stem Cells Sales Value (2021-2032)
  7. 6.3.2 North America Mesenchymal Stem Cells Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Mesenchymal Stem Cells Sales Value (2021-2032)
  10. 6.4.2 Europe Mesenchymal Stem Cells Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Mesenchymal Stem Cells Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Mesenchymal Stem Cells Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Mesenchymal Stem Cells Sales Value (2021-2032)
  16. 6.6.2 South America Mesenchymal Stem Cells Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Mesenchymal Stem Cells Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Mesenchymal Stem Cells Sales Value Share by Country, 2025 VS 2032
7 Mesenchymal Stem Cells Country-level Value Analysis
  1. 7.1 Global Mesenchymal Stem Cells Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Mesenchymal Stem Cells Sales Value by Country (2021-2032)
  3. 7.2.1 Global Mesenchymal Stem Cells Sales Value by Country (2021-2026)
  4. 7.2.2 Global Mesenchymal Stem Cells Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Mesenchymal Stem Cells Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Mesenchymal Stem Cells Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Mesenchymal Stem Cells Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Lonza
  2. 8.1.1 Lonza Company Information
  3. 8.1.2 Lonza Business Overview
  4. 8.1.3 Lonza Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Lonza Mesenchymal Stem Cells Product Portfolio
  6. 8.1.5 Lonza Recent Developments
  7. 8.2 Thermo Fisher
  8. 8.2.1 Thermo Fisher Company Information
  9. 8.2.2 Thermo Fisher Business Overview
  10. 8.2.3 Thermo Fisher Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Mesenchymal Stem Cells Product Portfolio
  12. 8.2.5 Thermo Fisher Recent Developments
  13. 8.3 Bio-Techne
  14. 8.3.1 Bio-Techne Company Information
  15. 8.3.2 Bio-Techne Business Overview
  16. 8.3.3 Bio-Techne Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Bio-Techne Mesenchymal Stem Cells Product Portfolio
  18. 8.3.5 Bio-Techne Recent Developments
  19. 8.4 ATCC
  20. 8.4.1 ATCC Company Information
  21. 8.4.2 ATCC Business Overview
  22. 8.4.3 ATCC Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  23. 8.4.4 ATCC Mesenchymal Stem Cells Product Portfolio
  24. 8.4.5 ATCC Recent Developments
  25. 8.5 MilliporeSigma
  26. 8.5.1 MilliporeSigma Company Information
  27. 8.5.2 MilliporeSigma Business Overview
  28. 8.5.3 MilliporeSigma Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  29. 8.5.4 MilliporeSigma Mesenchymal Stem Cells Product Portfolio
  30. 8.5.5 MilliporeSigma Recent Developments
  31. 8.6 PromoCell GmbH
  32. 8.6.1 PromoCell GmbH Company Information
  33. 8.6.2 PromoCell GmbH Business Overview
  34. 8.6.3 PromoCell GmbH Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  35. 8.6.4 PromoCell GmbH Mesenchymal Stem Cells Product Portfolio
  36. 8.6.5 PromoCell GmbH Recent Developments
  37. 8.7 Genlantis
  38. 8.7.1 Genlantis Company Information
  39. 8.7.2 Genlantis Business Overview
  40. 8.7.3 Genlantis Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Genlantis Mesenchymal Stem Cells Product Portfolio
  42. 8.7.5 Genlantis Recent Developments
  43. 8.8 Celprogen
  44. 8.8.1 Celprogen Company Information
  45. 8.8.2 Celprogen Business Overview
  46. 8.8.3 Celprogen Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Celprogen Mesenchymal Stem Cells Product Portfolio
  48. 8.8.5 Celprogen Recent Developments
  49. 8.9 Cell Applications
  50. 8.9.1 Cell Applications Company Information
  51. 8.9.2 Cell Applications Business Overview
  52. 8.9.3 Cell Applications Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cell Applications Mesenchymal Stem Cells Product Portfolio
  54. 8.9.5 Cell Applications Recent Developments
  55. 8.10 Cyagen Biosciences
  56. 8.10.1 Cyagen Biosciences Company Information
  57. 8.10.2 Cyagen Biosciences Business Overview
  58. 8.10.3 Cyagen Biosciences Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Cyagen Biosciences Mesenchymal Stem Cells Product Portfolio
  60. 8.10.5 Cyagen Biosciences Recent Developments
  61. 8.11 Axol Bioscience
  62. 8.11.1 Axol Bioscience Company Information
  63. 8.11.2 Axol Bioscience Business Overview
  64. 8.11.3 Axol Bioscience Mesenchymal Stem Cells Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Axol Bioscience Mesenchymal Stem Cells Product Portfolio
  66. 8.11.5 Axol Bioscience Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst